Loading stock…

ACM Research, Inc. (ACMR) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated today

ACM Research, Inc.

ACMRMarket cap $5.07BPrice $72.8

Country🇺🇸United States

SectorTechnology

IndustrySemiconductors

Makes cleaning equipment that strips away microscopic contaminants from silicon wafers during chip production. Nearly every advanced semiconductor factory needs this step, and China's chip independence push has turned this once-niche player into a critical supplier fueling explosive growth.

In Bastion Portfolios?

52W Return+91%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)+32%10

Revenue Forecast

Rev CAGR (1y)+29%9

Rev CAGR (3y)+27%10

Rev CAGR (5y)+23%10

Earnings Forecast

EPS Growth Y+1+45%9

EPS Growth Y+2+36%9

EPS Growth Y+3+46%9

Quality

Margins

EBIT Margin13%5

Net Income Margin14%7

Free Cash Flow Margin-11%2

Debt

Net Debt/EBITDA-6.610

Efficiency

ROE11%5

ROA8%8

Earnings Stability88

GEAR+AVERAGE60

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)332

P/E Ratio (Forward 3y)174

P/BV2.75

EV Multiples

EV/EBITDA Fwd222

EV/EBIT Fwd243

Yield

Free Cash Flow Yield-2.3%2

Dividend Yieldna–

Momentum

Short term

1 month return-5%5

3 month return-26%1

YTD return+84%10

Mid term

Price vs 52wHigh57%2

1 year return+73%10

Long term

3 year return+291%10

5 year return+93%7

Risk Shield

Price Risk

Beta1.71

Volatility87%1

Free Cash Flow

Free Cash Flow Margin-11%2

Free Cash Flow Yield-2.3%2

Quality

ROCE7%4

Earnings Stability88

Net Debt/EBITDA-6.610

02Growth

Is it actually growing, and how fast?

ACMRACM Research

Revenue FY25$901M

GROWTH RATING↗

VERY STRONG98 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+32%10

Revenue, next 1Y+29%9

Revenue, next 3Y, CAGR+27%10

Revenue, next 5Y, CAGR+23%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+45%9

EPS growth, FY27E+36%9

EPS growth, FY28E+46%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 98% of companies worldwide.

Revenue grew 32%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 27%/yr over the next 3 years, ahead of most of the market.10/10

The runway holds up: revenue is set to grow 23%/yr over five years.10/10

Earnings are set to grow faster than sales (EPS about 45%/yr vs revenue 27%/yr), so margins should widen.

WATCH

Revenue grew 32%/yr over the last 3 years; forecasts see it cooling to 27%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE45 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-5%5

3-month return-26%1

YTD return+84%10

MID & LONG-TERM▾SCORE

% of 52-week high57%2

1-year return+73%10

3-year return+291%10

5-year return+93%7

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +291% over three years and +93% over five, ahead of 80% of the market.

Strong recent results. The stock is outperforming so far this year (+84%).

WATCH

It's up 73% over the past year, but 43% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level over the past month (-5%).

WEAKNESSES

The stock is underperforming over three months (-26%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over three months.

04Value

Are you paying a fair price for it?

Stop guessing on ACM Research, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

ACMRACM Research

Revenue FY25$901M

GROWTH RATING↗

VERY STRONG98 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+32%10

Revenue, next 1Y+29%9

Revenue, next 3Y, CAGR+27%10

Revenue, next 5Y, CAGR+23%10

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+45%9

EPS growth, FY27E+36%9

EPS growth, FY28E+46%9

GROWTH ASSESSMENT

STRENGTHS

It out-grows 98% of companies worldwide.

Revenue grew 32%/yr over the last 3 years, ahead of 90% of companies worldwide.10/10

Revenue is set to grow 27%/yr over the next 3 years, ahead of most of the market.10/10

The runway holds up: revenue is set to grow 23%/yr over five years.10/10

Earnings are set to grow faster than sales (EPS about 45%/yr vs revenue 27%/yr), so margins should widen.

WATCH

Revenue grew 32%/yr over the last 3 years; forecasts see it cooling to 27%/yr.

WEAKNESSES

None flagged.

BOTTOM LINE

Elite Compounder

A top-tier grower that is slowing. The one thing to watch: the pace is cooling.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE45 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-5%5

3-month return-26%1

YTD return+84%10

MID & LONG-TERM▾SCORE

% of 52-week high57%2

1-year return+73%10

3-year return+291%10

5-year return+93%7

MOMENTUM ASSESSMENT

STRENGTHS

Magnificent long-term results. Long-term holders have seen +291% over three years and +93% over five, ahead of 80% of the market.

Strong recent results. The stock is outperforming so far this year (+84%).

WATCH

It's up 73% over the past year, but 43% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level over the past month (-5%).

WEAKNESSES

The stock is underperforming over three months (-26%).

BOTTOM LINE

Steady Compounder

Dependable multi-year returns with a calmer near-term tape. A reliable long-term trend rather than a short-term breakout. The one thing to watch: the stock is underperforming over three months.

04Value

Are you paying a fair price for it?

Stop guessing on ACM Research, Inc.. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community